Literature DB >> 18245937

Apnea in the newborn.

Satish Mishra1, Ramesh Agarwal, M Jeevasankar, Rajiv Aggarwal, Ashok K Deorari, Vinod K Paul.   

Abstract

Apnea, defined as cessation of breathing resulting in pathological changes in heart rate and oxygen saturation, is a common occurrence especially in preterm neonates. It is due to immaturity of the central nervous system (apnea of prematurity) or secondary to other causes such as metabolic disturbances etc. Secondary causes of apnea should be excluded before a diagnosis of apnea of prematurity is made. Methylxanthines and continuous positive airway pressure form the mainstay of treatment. Mechanical ventilation is reserved for apnea resistant to the above therapy. An approach to the management of apnea in neonates is described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245937     DOI: 10.1007/s12098-008-0008-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

Review 1.  Doxapram treatment for apnea in preterm infants.

Authors:  D J Henderson-Smart; P A Steer
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Current options in the management of apnea of prematurity.

Authors:  J Bhatia
Journal:  Clin Pediatr (Phila)       Date:  2000-06       Impact factor: 1.168

3.  Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants.

Authors:  D S Jardine; K Rogers
Journal:  Pediatrics       Date:  1989-02       Impact factor: 7.124

Review 4.  Prophylactic methylxanthine for extubation in preterm infants.

Authors:  D J Henderson-Smart; P G Davis
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 5.  Kinesthetic stimulation for treating apnea in preterm infants.

Authors:  D A Osborn; D J Henderson-Smart
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  Continuous positive airway pressure versus theophylline for apnea in preterm infants.

Authors:  D J Henderson-Smart; P Subramanian; P G Davis
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 7.  Methylxanthine treatment for apnea in preterm infants.

Authors:  D J Henderson-Smart; P Steer
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 8.  Apnea of prematurity.

Authors:  M J Miller; R J Martin
Journal:  Clin Perinatol       Date:  1992-12       Impact factor: 3.430

Review 9.  Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants.

Authors:  P G Davis; D J Henderson-Smart
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 10.  Carnitine supplementation for preterm infants with recurrent apnea.

Authors:  M Kumar; N S Kabra; B Paes
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18
  10 in total
  4 in total

1.  Olfactory stimulation by vanillin prevents apnea in premature newborn infants.

Authors:  Mitra Edraki; Hajar Pourpulad; Marzie Kargar; Narjes Pishva; Najaf Zare; Hashem Montaseri
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

2.  Low dose aminophylline effectively decreases the risk of post-operative apnea in premature infants.

Authors:  Seyed Amir Mohajerani; Fatemeh Roodneshin
Journal:  Tanaffos       Date:  2014

3.  Specific Premature Groups Have Better Benefits When Treating Apnea With Caffeine Than Aminophylline/Theophylline.

Authors:  Yi-Chieh Lin; Yin-Ling Tan; Ting-An Yen; Chien-Yi Chen; Po-Nien Tsao; Hung-Chieh Chou
Journal:  Front Pediatr       Date:  2022-02-24       Impact factor: 3.418

4.  Apparent life-threatening events in neonatal period: clinical manifestations and diagnostic challenges in a pediatric referral center.

Authors:  Maliheh Kadivar; Bahareh Yaghmaie; Bahar Allahverdi; Leila Shahbaznejad; Nosrat Razi; Ziba Mosayebi
Journal:  Iran J Pediatr       Date:  2013-08       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.